6533b855fe1ef96bd12b07fc

RESEARCH PRODUCT

Spatio‐temporal assessment of illicit drug use at large scale : evidence from 7 years of international wastewater monitoring

Iria González-mariñoJose Antonio Baz‐lombaNikiforos A. AlygizakisMaria Jesús Andrés‐costaRichard BadeAnne BannwarthLeon P. BarronFrederic BeenLisa BenagliaJean‐daniel BersetLubertus BijlsmaIgor BodíkAsher BrennerAndreas L. BrockDaniel A. BurgardErika CastrignanòAlberto CelmaChristophoros E. ChristophoridisAdrian CovaciOlivier DelémontPim VoogtDamien A. DevaultMário J. DiasErik EmkePierre EsseivaDespo Fatta-kassinosGanna FedorovaKonstantinos FytianosCobus GerberRoman GrabicEmma Gracia‐lorStefan GrünerTeemu GunnarEvroula HapeshiEster HeathBjörn HelmFélix HernándezAino KankaanpaaSara KarolakBarbara Kasprzyk‐hordernIvona Krizman‐matasicFoon Yin LaiWojciech LechowiczAlvaro LopesMiren López De AldaEster López‐garcíaArndís S. C. LöveNicola MastroianniGillian L. MceneffRosa MontesKelly MunroThomas NefauHerbert OberacherJake W. O'brienReinhard OertelKristin OlafsdottirYolanda PicóBenedek G. PlószFabio PoleselCristina PostigoJosé Benito QuintanaPedram RaminMalcolm J. ReidJack RiceRosario RodilNoelia Salgueiro‐gonzálezSara SchubertIvan SentaSusana M. SimõesMaja M. SremackiKatarzyna StyszkoSenka TerzicNikolaos S. ThomaidisKevin V. ThomasBen J. TscharkeRobin UdrisardAlexander L. N. NuijsViviane YargeauEttore ZuccatoSara CastiglioniChristoph Ort

subject

Research ReportWastewater‐based epidemiologyEcstasy/MDMAEpidemiologymedicine.medical_treatmentEcstasyPopulationIllicit drugs030508 substance abuseMedicine (miscellaneous)Wastewater-based epidemiology580 Plants (Botany)Methamphetamine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCocaineEnvironmental healthAmphetamine ; cocaine ; ecstasy ; MDMA ; illicit drugs ; methamphetamine ; wastewater-based epidemiologyIllicit drugMedicine030212 general & internal medicineeducationAmphetaminewastewater‐based epidemiologyeducation.field_of_studybusiness.industryPharmacology. TherapyMDMAResearch ReportsMethamphetamine6. Clean water3. Good healthStimulantPsychiatry and Mental healthInterdisciplinary Natural SciencesAmphetaminechemistryWastewaterMedicine (miscellaneous); Psychiatry and Mental healthEnvironmental ScienceBenzoylecgonine0305 other medical sciencebusinessmedicine.drug

description

Background and aims Wastewater‐based epidemiology is an additional indicator of drug use that is gaining reliability to complement the current established panel of indicators. The aims of this study were to: (i) assess spatial and temporal trends of population‐normalized mass loads of benzoylecgonine, amphetamine, methamphetamine and 3,4‐methylenedioxymethamphetamine (MDMA) in raw wastewater over 7 years (2011–17); (ii) address overall drug use by estimating the average number of combined doses consumed per day in each city; and (iii) compare these with existing prevalence and seizure data. Design Analysis of daily raw wastewater composite samples collected over 1 week per year from 2011 to 2017. Setting and Participants Catchment areas of 143 wastewater treatment plants in 120 cities in 37 countries. Measurements Parent substances (amphetamine, methamphetamine and MDMA) and the metabolites of cocaine (benzoylecgonine) and of Δ9‐tetrahydrocannabinol (11‐nor‐9‐carboxy‐Δ9‐tetrahydrocannabinol) were measured in wastewater using liquid chromatography–tandem mass spectrometry. Daily mass loads (mg/day) were normalized to catchment population (mg/1000 people/day) and converted to the number of combined doses consumed per day. Spatial differences were assessed world‐wide, and temporal trends were discerned at European level by comparing 2011–13 drug loads versus 2014–17 loads. Findings Benzoylecgonine was the stimulant metabolite detected at higher loads in southern and western Europe, and amphetamine, MDMA and methamphetamine in East and North–Central Europe. In other continents, methamphetamine showed the highest levels in the United States and Australia and benzoylecgonine in South America. During the reporting period, benzoylecgonine loads increased in general across Europe, amphetamine and methamphetamine levels fluctuated and MDMA underwent an intermittent upsurge. Conclusions The analysis of wastewater to quantify drug loads provides near real‐time drug use estimates that globally correspond to prevalence and seizure data.

10.1111/add.14767https://hdl.handle.net/10067/1662100151162165141